Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Wright Reports
$75.00
Provider: Reuters Investment Profile
$20.00
Provider: Motilal Oswal Securities Ltd.
$46.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Lupin Ltd launches generic Trilipix delayed‐release capsules 45 mg & 135 mg  in US 


Thursday, 5 Dec 2013 10:49pm EST 

Lupin Ltd:Says that its US subsidiary, Lupin Pharmaceuticals, Inc. has launched its generic Fenofibric Acid Delayed‐Release Capsules 45 mg and 135 mg.Says it had earlier received final approval from the US FDA for the same. 

Company Quote

1395.65
-0.3 -0.02%
6:29am EDT